AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Helix's 15min chart triggers MACD Death Cross, KDJ Death Cross.
ByAinvest
Monday, Aug 11, 2025 1:03 pm ET1min read
According to Helix's 15-minute chart, a MACD Death Cross and KDJ Death Cross were triggered on August 11, 2025 at 13:00. This indicates that the stock price has the potential to continue declining, as the momentum of the stock price is shifting towards the downside and may further decrease.
Helix Acquisition Corp. II (HLXB), a special purpose acquisition company (SPAC) sponsored by affiliates of Cormorant Asset Management, has retained approximately $120 million in its trust account after redemptions by public shareholders. This amount represents more than 60% of the cash held in trust, according to a press release dated August 6, 2025 [1].The redemption rate of 60% is one of the second lowest for a biotech de-SPAC transaction since 2022. The gross proceeds from the trust account and private placement (PIPE) financing are expected to total approximately $382 million, with $120 million from the trust account and approximately $261 million from the PIPE financing led by Cormorant Asset Management and including several other investors [1].
The transaction is expected to raise a significant amount of capital, which will be used to fund the business combination with BridgeBio Oncology Therapeutics (BBOT). BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. The combined company aims to improve outcomes for patients with cancers driven by these prevalent oncogenes.
The business combination is subject to the satisfaction or waiver of closing conditions. Both Helix and BBOT intend to proceed expeditiously with the closing of the transaction.
In addition to the financial implications, the technical analysis of Helix's stock also provides insights. According to the 15-minute chart, a MACD Death Cross and KDJ Death Cross were triggered on August 11, 2025, at 13:00. This indicates a potential shift in the stock price's momentum towards the downside, suggesting that the stock price may continue to decline [2].
References:
[1] https://www.globenewswire.com/news-release/2025/08/06/3128242/0/en/Helix-Acquisition-Corp-II-Retains-More-than-60-of-Trust-Account-after-Redemptions-in-connection-with-Business-Combination-with-BridgeBio-Oncology-Therapeutics.html
[2] (Provided source material for the technical analysis)
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet